https://www.selleckchem.com/pr....oducts/epalrestat.ht
001). Control subjects did not show any response to the L-ASA challenge. A novel clinical score demonstrated accuracy in classifying the hypersensitivity to aspirin and/or NSAIDs when patients avoid LTRA (33 of 37). Patients with AERD without LTRA showed a greater positive response to the L-ASA challenge than those taking this drug; therefore, LTRA treatment should be discontinued before the challenge for optimal diagnostic accuracy. Patients with AERD without LTRA showed a greater positive response to the L-ASA challenge than those
Like
Comment
Share
